MPW Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -0.72%, SMA50 -1.66%, SMA200 5.68%). The stock’s 14-day RSI is 46.02 (neutral), while the ATR of 0.16 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.93% below its high and over 30.79% above its low. Average 10-day trading volume of 8.03 million shares is slightly above the 3-month average of 7.09 million, indicating heightened recent market interest.

Medical Properties Trust, Inc. last paid a dividend of 0.33 per share, this equals a trailing yield of roughly 15.71%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.69. This means the shares are trading above this model’s fair value.

The latest quarter delivered EPS of -$0.03. The next quarter is forecast at $0.01. Next year's EPS is expected at $125.24. Analyst sentiment is bearish. Analyst rating data shows there are 1 Strong Buy ratings, 0 Buy ratings, 2 Hold ratings, 0 Sell rating and 3 Strong Sell ratings. Price targets range from $9.00 to $4.50. The high target offers 75.1% upside. The low target suggests -12.45% downside. The mean target is $5.50. This offers 7.0% upside. Medical Properties Trust, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended October 30, 2025, missed forecasts by -117.11%. The prior quarter beat by -6.67%. Over the last six quarters, Apple has recorded several small beats. These include -370.0% in August 08, 2024.

Medical Properties Trust, Inc. (NYSE:MPW) closed at $5.20 USD, gaining $0.07 (1.27%) from the previous close of $5.13. The stock is currently mid-range between its 52-week high and low $3.95 and $6.34. With a market capitalization of about $3.13 billion, Medical Properties Trust, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.46). Key stats such as the average daily volume over the past year has been around 7.32 million shares, volume is running light vs its 52-week average. Headquartered in Birmingham, AL, Medical Properties Trust, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Edward K. Aldag Jr., the company employs approximately 118 people and listed since July 08, 2005. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.

Medical Properties Trust, Inc. has 601.10 million shares outstanding. The public float is 493.45 million shares, elevated short interest at 41.54% of float. This equals 173.77 million shares. The short ratio is 17.9 days. Institutional investors hold 72.0% of the float. Insiders own 17.3%. Aldag Edward K JR holds 3.50 million shares, HAMNER R STEVEN has 1.96 million shares and McLean Emmett E has 1.28 million shares. Over the past six months, insider transactions show net selling. They sold 61.00 thousand shares across 2 transactions.

Medical Properties Trust, Inc. trades at a P/E ratio of -4.39, slightly below the S&P 500 average, with a price-to-sales ratio of 3.32 and a price-to-book ratio of 0.67 suggesting the stock is closer to book value. The P/FCF stands at 21.08, also above market averages.

Medical Properties Trust, Inc. (NYSE:MPW) shares are flat 2.8% year-to-date currently trading near 52-week highs band. Short-term momentum has been flat over the last quarter, despite recent volatility. Valuation shows Medical Properties Trust, Inc. trading at a premium to the broader market with a P/E of -4.39. Analyst sentiment is cautious, with the majority of ratings in Underweight territory and a mean price target of $12.70, suggesting 147.08% upside. Our AI forecast model points to short-term strength (2.53% over two weeks), a medium-term rise (45.53% over three months), and a longer-term gain (50.58% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Medical Properties Trust, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.53%, with price expected at $5.27 by February 03, 2026, within a range of $5.11 to $5.42 3-Month Outlook: Projected rise of 45.53%, reaching $7.48 by April 16, 2026, with a range of $7.30 to $7.69. 1-Year Outlook: Projected gain of 50.58%, with price at $7.74 by January 15, 2027, within a range of $0.00 to $15.77.